JPS57140726A - Purification of physiologically active substance having carcinostatic action - Google Patents

Purification of physiologically active substance having carcinostatic action

Info

Publication number
JPS57140726A
JPS57140726A JP56209841A JP20984181A JPS57140726A JP S57140726 A JPS57140726 A JP S57140726A JP 56209841 A JP56209841 A JP 56209841A JP 20984181 A JP20984181 A JP 20984181A JP S57140726 A JPS57140726 A JP S57140726A
Authority
JP
Japan
Prior art keywords
physiologically active
substance
action
solution
eluted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP56209841A
Other languages
English (en)
Other versions
JPS6363559B2 (ja
Inventor
Katsuyuki Haranaka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asahi Kasei Corp
Dainippon Pharmaceutical Co Ltd
Asahi Chemical Industry Co Ltd
Original Assignee
Dainippon Pharmaceutical Co Ltd
Asahi Chemical Industry Co Ltd
Asahi Kasei Kogyo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Pharmaceutical Co Ltd, Asahi Chemical Industry Co Ltd, Asahi Kasei Kogyo KK filed Critical Dainippon Pharmaceutical Co Ltd
Priority to JP56209841A priority Critical patent/JPS57140726A/ja
Publication of JPS57140726A publication Critical patent/JPS57140726A/ja
Publication of JPS6363559B2 publication Critical patent/JPS6363559B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
JP56209841A 1981-12-28 1981-12-28 Purification of physiologically active substance having carcinostatic action Granted JPS57140726A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP56209841A JPS57140726A (en) 1981-12-28 1981-12-28 Purification of physiologically active substance having carcinostatic action

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56209841A JPS57140726A (en) 1981-12-28 1981-12-28 Purification of physiologically active substance having carcinostatic action

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP55143197 Division

Publications (2)

Publication Number Publication Date
JPS57140726A true JPS57140726A (en) 1982-08-31
JPS6363559B2 JPS6363559B2 (ja) 1988-12-07

Family

ID=16579502

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56209841A Granted JPS57140726A (en) 1981-12-28 1981-12-28 Purification of physiologically active substance having carcinostatic action

Country Status (1)

Country Link
JP (1) JPS57140726A (ja)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1984001288A1 (en) * 1982-10-06 1984-04-12 Takeshi Makitsubo Process for extracting tumor necrosis factor from macrophage
JPS6030688A (ja) * 1983-07-28 1985-02-16 Dainippon Pharmaceut Co Ltd ヒト癌壊死因子の製造法

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1984001288A1 (en) * 1982-10-06 1984-04-12 Takeshi Makitsubo Process for extracting tumor necrosis factor from macrophage
JPS6030688A (ja) * 1983-07-28 1985-02-16 Dainippon Pharmaceut Co Ltd ヒト癌壊死因子の製造法

Also Published As

Publication number Publication date
JPS6363559B2 (ja) 1988-12-07

Similar Documents

Publication Publication Date Title
JPH0231689A (ja) 百日咳トキシンの精製法
FR2603581B1 (fr) Procede pour isoler et purifier des aminoacides par chromatographie
ES8404372A1 (es) Procedimiento para preparar un inactivador, eventualmente exento de virus de hepatitis y eventualmente liofilizable, de la c1-esterasa del sistema de complemento
DE3263327D1 (en) Immune adsorbent, adsorbing device and blood purifying apparatus
EP0208215A3 (en) Purification of blood clotting factors and other blood proteins on non-carbohydrate sulfated matrices
FR2524891B1 (fr) Procede pour purifier une substance proteinee douee d'activite antitumorale
JPS5630925A (en) Purification of human growth hormone
ES8505696A1 (es) Un procedimiento de cromatografia de afinidad para la preparacion de antibioticos purificados de la clase de la vancomicicina.
EP0385118A3 (en) Use of compounds containing or binding sialic acid to neutralize bacterial toxins
JPS57140726A (en) Purification of physiologically active substance having carcinostatic action
SE8600641L (sv) Nitrilofora eda-absorbenter
IE840694L (en) Process for the isolation of tylosin
EP1078911A3 (de) Verfahren zum Feinreinigen einer wässrigen Lösung, die eine fermentativ hergestellte organische Säure enthält
SU644796A1 (ru) Способ очистки протеолитических ферментов
MY130013A (en) Purification of human interleukin-4 from a secreted escherichia coli mutant.
JPS56108798A (en) Purification of erythropoietin
JPS5498741A (en) Novel antibiotic and its preparation
JPS57203015A (en) Purifying method of human urinary callicrein
MA20150A1 (fr) Derives de l'acide bicyclo (3,2-1) octane carboxylique et leur procede de preparation et leur application therapeutique.
ES8304150A1 (es) "un procedimiento para purificar una sustancia proteinica fisiologicamente activa que tiene actividad antitumoral".
FR2552762B1 (fr) Nouveaux amides piperaziniques et homopiperaziniques derives de l'acide 3,4-dioxymethylene cinnamique, leur procede de preparation et leur application en therapeutique
JPS5599191A (en) Purification of kallikrein in human urine
KR910015699A (ko) 리포코틴의 정제방법
DK163582A (da) Fremgangsmaade til rensning af et fysiologisk aktivt stof med antitumorvirkning
NZ242298A (en) Purification of lantibiotics by treating the fermentation broth with a styrene copolymer matrix, cation exchange chromatography, hydrophobic interaction chromatography and desalting